SG Americas Securities, LLC - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 136 filers reported holding IMMUNITYBIO INC in Q2 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q3 2023$57
-38.7%
33,697
-33.9%
0.00%0.0%
Q1 2023$93
+5.7%
51,013
+193.2%
0.00%0.0%
Q4 2022$88
-100.0%
17,400
-82.2%
0.00%
-83.3%
Q3 2022$485,000
+34.0%
97,662
+0.3%
0.01%
+50.0%
Q2 2022$362,000
+29.3%
97,406
+94.8%
0.00%
+100.0%
Q1 2022$280,000
+75.0%
49,996
+89.5%
0.00%
+100.0%
Q4 2021$160,000
-78.8%
26,379
-65.9%
0.00%
-75.0%
Q3 2021$754,000
+63.6%
77,385
+139.9%
0.00%
+100.0%
Q2 2021$461,000
+50.2%
32,260
+149.7%
0.00%0.0%
Q1 2021$307,00012,9200.00%
Other shareholders
IMMUNITYBIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders